Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-05-21
2008-11-04
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S251000
Reexamination Certificate
active
07446108
ABSTRACT:
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following structure:including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, R1, R2, R4, R5, R6, A, X, and Y are as defined herein. Compositions containing a CRF receptor antagonist in combination with a pharmaceutically acceptable carrier are also disclosed, as well as methods for use of the same.
REFERENCES:
patent: 6514982 (2003-02-01), Haddach et al.
patent: WO 97/44038 (1997-11-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 00/27846 (2000-05-01), None
patent: WO 03/008414 (2003-01-01), None
Banker, Gilbert S. et al., Modem Pharmaceutics, Marcel Dekker, New York, 1996, pp. 451 and 596.
Wolff, Manfred E., Burger's Medicinal Chemistry and Drug Discovery, Fifth Ed., vol. 1: Principles and Practice, John Wiley & Sons, 1995, pp. 975-977.
Akimoto, et al., Chem. Abstracts, 1993, vol. 118, No. 21, XP002207951.
Akimoto et al. Chem. Abstracts, 118(21): 1993. XP002207951.
Di Fabio Romano
Gentile Gabriella
St Denis Yves
Leeser Erich A
Madden Laura K.
McCarthy Mary
Neurocrine, Inc.
Sauermelch Loretta
LandOfFree
Tri-and tetraaza-acenaphthylen derivatives as CRF receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tri-and tetraaza-acenaphthylen derivatives as CRF receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tri-and tetraaza-acenaphthylen derivatives as CRF receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024758